Dehydroepiandrosterone in systemic lupus erythematosus

The 1982 revised criteria for the classification of systemic lupus erythematosus

Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · see citing works

Derivation of the sledai. A disease activity index for lupus patients

Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H., Austin, A., Bell, A., Bloch, D. A., Corey, P. N., Decker, J. L., et al. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350606 · Cited by 4,570 · see citing works

Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Linker‐Israeli, M., Bakke, A. C., Kitridou, R. C., Gendler, S. J., Gillis, S. A., & Horwitz, D. A. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2651 · Cited by 453 · see citing works

Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.

Alcocer-Varela, J. C., & Alarcón-Segovia, D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110579 · Cited by 422 · see citing works

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414 · see citing works

Frequency of lupus flare in pregnancy: The hopkins lupus pregnancy center experience

Petri, M., Howard, D., & Repke, J. T. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341210 · Cited by 392 · see citing works

Physiological importance of dehydroepiandrosterone.

Eberling, P., & Koivisto, V. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92587-9 · Cited by 365 · see citing works

An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan Use

Belongia, E. A., Hedberg, C. W., Gleich, G. J., White, K. E., Mayeno, A. N., Loegering, D. A., Dunnette, S. L., Pirie, P. L., MacDonald, K. L., & Osterholm, M. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008093230601 · Cited by 356 · see citing works

Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function.

Daynes, R. A., Araneo, B. A., Dowell, T., Huang, K. L., & Dudley, D. J. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.4.979 · Cited by 343 · see citing works

Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.

Steinberg, A. D., Roths, J. B., Murphy, E. D., Steinberg, R. T., & Raveche, E. S. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.2.871 · Cited by 326 · see citing works

Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells

Daynes, R. A., Dudley, D. J., & Araneo, B. A. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200413 · Cited by 326 · see citing works

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

MORTOLA, J. F., & YEN, S. S. C. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-3-696 · Cited by 311 · see citing works

Androgenic Hormones Modulate Autoantibody Responses and Improve Survival in Murine Lupus

Roubinian, J. R., Papoian, R., & Talal, N. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108729 · Cited by 300 · see citing works

Low plasma androgens in women with systemic lupus erythematosus

Lahita, R. G., Bradlow, H. L., Ginzler, E. M., Pang, S., & New, M. I. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300301 · Cited by 284 · see citing works

Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells.

Suzuki, T., Suzuki, N., Daynes, R. A., & Engleman, E. G. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(05)80024-8 · Cited by 277 · see citing works

Alterations of estrogen metabolism in systemic lupus erythematosus

Lahita, R. G., Bradlow, H. L., Kunkel, H. G., & Fishman, J. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780221106 · Cited by 220 · see citing works

Control of adrenal androgen secretion.

Parker, L. N., & Odell, W. (1980) · Endocrine reviews · doi:10.1210/edrv-1-4-392 · Cited by 184 · see citing works

An open study of dehydroepiandrosterone in systemic lupus erythematosus

van Vollenhoven, R., Engleman, E. G., & McGuire, J. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370906 · Cited by 157 · see citing works

Systemic lupus erythematosus

Roubenoff, R., & Hochberg, M. C. (1991) · Springer eBooks · doi:10.1007/978-94-011-3896-3_9 · Cited by 149 · see citing works

Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone.

Lucas, J. A., Ahmed, S. A., Casey, M. L., & MacDonald, P. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111929 · Cited by 145 · see citing works

Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus

Gutierrez‐Ramos, J. C., Andreu, J. L., Revilla, Y., Viñuela, E., & Martínez-A, C. (1990) · Nature · doi:10.1038/346271a0 · Cited by 136 · see citing works

Effect of Pregnancy on Course of Systemic Lupus Erythematosus

Mund, A., Simson, J., & Rothfield, N. F. (1963) · JAMA · doi:10.1001/jama.1963.03700110049009 · Cited by 119 · see citing works

Control of Adrenal Androgen Secretion

Parker, L. N. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30275-5 · Cited by 114 · see citing works

Low plasma androgens in women with active or quiescent systemic lupus erythematosus

Jungers, P., NAHOUL, K., Pelissier, C., Dougados, M., Tron, F., & Bach, J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250415 · Cited by 112 · see citing works

Estrogen, progesterone, and testosterone: Can they be used to treat autoimmune diseases?

van Vollenhoven, R., & McGuire, J. L. (1994) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.61.4.276 · Cited by 91 · see citing works

Sex steroids and the immune system—I. Sex difference in autoimmune disease in NZB/NZW hybrid mice

Siiteri, P. K., Jones, L. A., Roubinian, J. R., & Talal, N. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90303-9 · Cited by 88 · see citing works

Increased oxidation of testosterone in systemic lupus erythematosus

Lahita, R. G., Kunkel, H. G., & Bradlow, H. L. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780261215 · Cited by 83 · see citing works

Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)

Suzuki, T., Suzuki, N., Engleman, E. G., Mizushima, Y., & Sakane, T. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05541.x · Cited by 82 · see citing works

Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement.

Agnello, V., Pariser, K. M., Gell, J., Gelfand, J., & Turksoy, R. N. (1983) · PubMed · Cited by 71 · see citing works

Therapeutic studies in new zealand mice

Melez, K. A., Boegel, W. A., & Steinberg, A. D. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230108 · Cited by 67 · see citing works

DHEAS as an Effective Vaccine Adjuvant in Elderly Humans

Araneo, B. A., Dowell, T., Woods, M. L., Daynes, R. A., JUDD, M., & Evans, T. G. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17384.x-i1 · Cited by 60 · see citing works

Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack of improvement in women.

Rg, L., Cheng, C. Y., Monder, C., & Cw, B. (1992) · PubMed · Cited by 47 · see citing works

Natural Regulators of T-Cell Lymphokine Production In Vivo

Daynes, R. A., & Araneo, B. A. (1992) · Journal of Immunotherapy · doi:10.1097/00002371-199210000-00006 · Cited by 44 · see citing works

Dehydroisoandrosterone prevention of autoimmune disease in NZB/W F1 mice: lack of an effect on associated immunological abnormalities

Matsunaga, A., Miller, B. C., & Cottam, G. L. (1989) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(89)90084-6 · Cited by 22 · see citing works

Catabolic effects and the influence on hormonal variables under treatment with gynodian-depot® or dehydroepiandrosterone (DHEA) oenanthate

Abrahamsson, L., & Hackl, H. (1981) · Maturitas · doi:10.1016/0378-5122(81)90029-3 · Cited by 11 · see citing works

Gender differences in autoimmune disease

Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074 · see citing works

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544 · see citing works

DHEA and DHEA‐S: A Review

Kroboth, P. D., Salek, F. S., Pittenger, A. L., Fabian, T. J., & Frye, R. F. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922007903 · Cited by 523 · see citing works

Understanding how we age: insights into inflammaging

Baylis, D., Bartlett, D. B., Patel, H. P., & Roberts, H. C. (2013) · Longevity & Healthspan · doi:10.1186/2046-2395-2-8 · Cited by 413 · see citing works

Serum Dehydroepiandrosterone (DHEA) and DHEA Sulfate Are Negatively Correlated with Serum Interleukin-6 (IL-6), and DHEA Inhibits IL-6 Secretion from Mononuclear Cells in Man in Vitro: Possible Link between Endocrinosenescence and Immunosenescence

Straub, R. H., Konecná, L., Hrach, S., Rothe, G., Kreutz, M. P., Schölmerich, J., Falk, W., & Lang, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4876 · Cited by 352 · see citing works

Long-term course and outcome of functional capacity in rheumatoid arthritis: The effect of disease activity and radiologic damage over time

Drossaers-Bakker, K. W., de Buck, M., van Zeben, D., Zwinderman, A. H., Breedveld, F. C., & Hazes, J. M. W. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9 · Cited by 373 · see citing works

Systemic lupus erythematosus

Ruiz‐Irastorza, G., Khamashta, M. A., Castellino, G., & Hughes, G. R. V. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04239-2 · Cited by 265 · see citing works

Dehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME)

Traish, A. M., Kang, H. P., Saad, F., & Guay, A. T. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02523.x · Cited by 237 · see citing works

Neural immune pathways and their connection to inflammatory diseases.

Eskandari, F., Webster, J. I., & Sternberg, E. M. (2003) · Arthritis Research · doi:10.1186/ar1002 · Cited by 201 · see citing works

Systemic lupus erythematosus in childhood

Klein‐Gitelman, M., Reiff, A. O., & Silverman, E. D. (2002) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(02)00015-7 · Cited by 198 · see citing works

DHEA, Important Source of Sex Steroids in Men and Even More in Women

Labrie, F. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)82004-7 · Cited by 183 · see citing works

Outcome measures to be used in clinical trials in systemic lupus erythematosus.

Strand, V., Gladman, D. D., Isenberg, D. A., Petri, M., Smolen, J. S., & Tugwell, P. (1999) · PubMed · Cited by 179 · see citing works

Sex hormones and systemic lupus erythematosus: Review and meta‐analysis

McMurray, R. W., & May, W. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11105 · Cited by 175 · see citing works

Dehydroepiandrosterone treatment of women with mild‐to‐moderate systemic lupus erythematosus: A multicenter randomized, double‐blind, placebo‐controlled trial

Chang, D., Lan, J., Lin, H., & Luo, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10615 · Cited by 164 · see citing works

Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis.

CASTAGNETTA, L. A. M., Carruba, G., Granata, O. M., Stefano, R., Miele, M., Schmidt, M., Cutolo, M., & Straub, R. H. (2003) · PubMed · Cited by 160 · see citing works

Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: A double‐blind, randomized, placebo‐controlled trial

Petri, M., Lahita, R. G., van Vollenhoven, R., Merrill, J. T., Schiff, M. H., Ginzler, E. M., Strand, V., Kunz, A. Y., Gorelick, K. J., & Schwartz, K. E. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10364 · Cited by 154 · see citing works

DHEA treatment: myth or reality?

Allolio, B., & Arlt, W. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00617-3 · Cited by 153 · see citing works

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus

Petri, M., Mease, P. J., Merrill, J. T., Lahita, R. G., Iannini, M. J., Yocum, D. E., Ginzler, E. M., Katz, R. S., Gluck, O. S., Genovese, M. C., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20427 · Cited by 144 · see citing works

A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

van Vollenhoven, R. F., Park, J. L., Genovese, M. C., West, J. P., & McGuire, J. L. (1999) · Lupus · doi:10.1191/096120399678847588 · Cited by 144 · see citing works

Dehydroepiandrosterone Supplementation in Healthy Men with an Age-Related Decline of Dehydroepiandrosterone Secretion

Arlt, W., Callies, F., Koehler, I., van Vlijmen, J. C., Faßnacht, M., Strasburger, C. J., Seibel, M. J., Huebler, D., Ernst, M. E., Oettel, M., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7974 · Cited by 139 · see citing works

DHEAS Deficiency During Consumption of Sustained-Action Prescribed Opioids: Evidence for Opioid-Induced Inhibition of Adrenal Androgen Production

Daniell, H. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.04.011 · Cited by 140 · see citing works

Hormonal modulation of B cell development and repertoire selection

Grimaldi, C. M., Hill, L., Xu, X., Peeva, E., & Diamond, B. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.05.014 · Cited by 122 · see citing works

Lupus arthritis

Grossman, J. M. (2009) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2009.04.003 · Cited by 122 · see citing works

Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease

Straub, R. H., Vogl, D., Gross, V., Lang, B., Schölmerich, J., & Andus, T. (1998) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00535.x · Cited by 114 · see citing works

Hormones and immune function: implications of aging

Arlt, W., & Hewison, M. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00109.x · Cited by 110 · see citing works

The process of aging changes the interplay of the immune, endocrine and nervous systems

Straub, R. H., Cutolo, M., Zietz, B., & Schölmerich, J. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00289-5 · Cited by 110 · see citing works

Dehydroepiandrosterone and ageing.

Arlt, W. (2004) · Best practice & research. Clinical endocrinology & metabolism · doi:10.1016/j.beem.2004.02.006 · Cited by 121 · see citing works

Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial

Hartkamp, A., Geenen, R., Godaert, G. L. R., Bootsma, H., Kruize, A. A., Bijlsma, J. W. J., & Derksen, R. H. W. M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071563 · Cited by 104 · see citing works

GENETICS OF SYSTEMIC LUPUS ERYTHEMATOSUS

Sullivan, K. E. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70137-x · Cited by 89 · see citing works

Androgen therapy with dehydroepiandrosterone

Buvat, J. (2003) · World Journal of Urology · doi:10.1007/s00345-003-0367-7 · Cited by 87 · see citing works

Longitudinal changes in dehydroepiandrosterone concentrations in men and women

Nafziger, A. N., Bowlin, S. J., Jenkins, P. L., & Pearson, T. A. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90181-0 · Cited by 82 · see citing works

Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock

Arlt, W., Hammer, F., Sanning, P., Butcher, S. K., Lord, J. M., Allolio, B., Annane, D., & Stewart, P. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2258 · Cited by 82 · see citing works

High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis

Straub, R. H., Zeuner, M., Lock, G., Schölmerich, J., & Lang, B. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.4.426 · Cited by 76 · see citing works

Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice

Yang, L.-Y., Chen, A., Kuo, Y., & Lin, C.-Y. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90171-3 · Cited by 74 · see citing works

Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus

Cutolo, M., Sulli, A., Villaggio, B., SERIOLO, B., & Accardo, S. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.10.573 · Cited by 74 · see citing works

Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus

Nordmark, G., Bengtsson, C., Larsson, A. O., Karlsson, F. A., Sturfelt, G. K., & Rönnblom, L. (2005) · Autoimmunity · doi:10.1080/08916930500285550 · Cited by 70 · see citing works

A critical review of clinical trials in systemic lupus erythematosus

Mahieu, M. A., Strand, V., Simon, L. S., Lipsky, P. E., & Ramsey‐Goldman, R. (2016) · Lupus · doi:10.1177/0961203316652492 · Cited by 71 · see citing works

Lupus erythematosus and nutrition: A review of the literature

Brown, A. C. (2000) · Journal of Renal Nutrition · doi:10.1053/jren.2000.16323 · Cited by 68 · see citing works

Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly?

Genazzani, A. D., Lanzoni, C., & Genazzani, A. R. (2007) · Drugs & Aging · doi:10.2165/00002512-200724030-00001 · Cited by 69 · see citing works

Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor

Straub, R. H., Lehle, K., Herfarth, H. H., Weber, M., Falk, W., Preuner, J. G., & Schölmerich, J. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460365 · Cited by 67 · see citing works

Uses of DHEA in aging and other disease states

JOHNSON, M., Bebb, R. A., & Sirrs, S. M. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00369-4 · Cited by 66 · see citing works

Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis

Härle, P., Pongratz, G., Weidler, C., Büttner, R., Schölmerich, J., & Straub, R. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011619 · Cited by 63 · see citing works

Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus.

Patavino, T., & Brady, D. M. (2001) · PubMed · Cited by 59 · see citing works

Prominent sex steroid metabolism in human lymphocytes

Zhou, Z., Shackleton, C. H. L., Pahwa, S. G., White, P. C., & Speiser, P. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00052-5 · Cited by 59 · see citing works

Novel therapeutic agents for systemic lupus erythematosus

Gescuk, B. D., & Davis, J. C. (2002) · Current Opinion in Rheumatology · doi:10.1097/00002281-200209000-00006 · Cited by 70 · see citing works

Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option

Bonam, S. R., Wang, F., & Muller, S. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.009 · Cited by 55 · see citing works

Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus

Straub, R. H., Weidler, C., Demmel, B., Herrmann, M., Kees, F., Schmidt, M., Schölmerich, J., & Schedel, J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.014274 · Cited by 55 · see citing works

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus

van Vollenhoven, R. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.1.23 · Cited by 54 · see citing works

Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus

Derksen, R. H. W. M. (1998) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(98)80013-9 · Cited by 55 · see citing works

OVERVIEW OF CELLULAR IMMUNE FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS

Tsokos, G. C. (2004) · Elsevier eBooks · doi:10.1016/b9-78-012433-9/01950-0053 · Cited by 54 · see citing works

Dehydroepiandrosterone for systemic lupus erythematosus

Crosbie, D., Black, C., McIntyre, L., Royle, P., & Thomas, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005114.pub2 · Cited by 54 · see citing works

Pharmacology And Therapeutic Effects of Dehydroepiandrosterone In Older Subjects

Legrain, S., & Girard, L. (2003) · Drugs & Aging · doi:10.2165/00002512-200320130-00001 · Cited by 54 · see citing works

A Novel Dehydroepiandrosterone Analog Improves Functional Recovery in a Rat Traumatic Brain Injury Model

Malik, A. S., Narayan, R. K., Wendling, W. W., Cole, R. W., Pashko, L. L., Schwartz, A. G., & Strauss, K. I. (2003) · Journal of Neurotrauma · doi:10.1089/089771503765355531 · Cited by 53 · see citing works

The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects

Straub, R. H., Schuld, A., Mullington, J. M., Haack, M., Schölmerich, J., & Pollmächer, T. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750467 · Cited by 53 · see citing works

Androgen Supplementation in Older Women: Too Much Hype, Not Enough Data

Padero, M., Bhasin, S., & Friedman, T. C. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50273.x · Cited by 53 · see citing works

Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial

Hartkamp, A., Geenen, R., Godaert, G. L. R., Bijl, M., Bijlsma, J. W. J., & Derksen, R. H. W. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117036 · Cited by 51 · see citing works

Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus

Gordon, C., Wallace, D. J., Shinada, S., KALUNIAN, K. C., Forbess, L. J., Braunstein, G. D., & Weisman, M. H. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/kem342 · Cited by 50 · see citing works

Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study

Andus, T., Klebl, F. H., Rogler, G., Bregenzer, N., Schölmerich, J., & Straub, R. H. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01433.x · Cited by 50 · see citing works

Replacement therapy with DHEA plus corticosteroids in patients with chronic inflammatory diseases - substitutes of adrenal and sex hormones

Straub, R. H., Schölmerich, J., & Zietz, B. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/pl00022854 · Cited by 47 · see citing works

Androgens indirectly accelerate thymocyte apoptosis

Dulos, G. J., & Bagchus, W. M. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00029-1 · Cited by 48 · see citing works

Interventions for cutaneous disease in systemic lupus erythematosus

Hannon, C. W., McCourt, C., Lima, H., Chen, S. C., & Bennett, C. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007478.pub2 · Cited by 52 · see citing works

Lymphocytes Stimulate Dehydroepiandrosterone Production through Direct Cellular Contact with Adrenal Zona Reticularis Cells: A Novel Mechanism of Immune-Endocrine Interaction

Wolkersdörfer, G. W., Lohmann, T., Marx, C., Schröder, S., Pfeiffer, R., Hd, S., Scherbaum, W. A., Chrousos, G. P., & Bornstein, S. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6110 · Cited by 51 · see citing works

Correction for age of anticardiolipin antibodies cut-off points

Rapizzi, E., Ruffatti, A., Tonello, M., Piccoli, A., Calligaro, A., Sfriso, P., & TODESCO, S. (2000) · Journal of Clinical Laboratory Analysis · doi:10.1002/(sici)1098-2825(2000)14:3 · Cited by 2 · see citing works

Dehydroepiandrosterone in systemic lupus erythematosus

Sawalha, A. H., & Kovats, S. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0046-1 · Cited by 44 · see citing works

Newer Drugs for the Treatment of Lupus Nephritis

Kuiper-Geertsma, D. G., & Derksen, R. H. W. M. (2003) · Drugs · doi:10.2165/00003495-200363020-00004 · Cited by 43 · see citing works

Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate

Valtýsdóttir, S. T., Wide, L., & Hallgren, R. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.875 · Cited by 42 · see citing works

The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies

Salek, F. S., Bigos, K. L., & Kroboth, P. D. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011274 · Cited by 40 · see citing works

The Importance of Systemic Cytokines in the Pathogenesis of Polymicrobial Sepsis and Dehydroepiandrosterone Treatment in a Rodent Model

Hildebrand, F., Pape, H., Hoevel, P., Krettek, C., & van Griensven, M. (2003) · Shock · doi:10.1097/01.shk.0000081408.57952.22 · Cited by 40 · see citing works

DHEA: A Biologist's Perspective

Hornsby, P. J. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb02941.x · Cited by 41 · see citing works

Systemic Lupus Erythematosus

Petri, M. (2006) · JCR Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000200420.67262.04 · Cited by 39 · see citing works

Treatment of systemic lupus erythematosus

Mosca, M., Ruiz‐Irastorza, G., Khamashta, M. A., & Hughes, G. R. V. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00037-6 · Cited by 40 · see citing works

The Use of Dehydroepiandrosterone Therapy in Clinical Practice

Cameron, D. R., & Braunstein, G. D. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504020-00004 · Cited by 38 · see citing works

DEHYDROEPIANDROSTERONE IN SYSTEMIC LUPUS ERYTHEMATOSUS

van Vollenhoven, R. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70142-3 · Cited by 36 · see citing works

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

Bertsias, G. K., Ioannidis, J. P. A., Boletis, J. N., Bombardieri, S., Cervera, R., Dostál, C., Font, J., Gilboe, I.-M., Houssiau, F., Huizinga, T. W. J., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083030 · Cited by 36 · see citing works

Is there a case for DHEA replacement?

Nippoldt, T. B., & Nair, K. S. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80286-3 · Cited by 36 · see citing works

Attenuation of house dust mite Dermatophagoides farinae‐induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down‐regulation of TH2 response

Yu, F., Yang, Y., Lei, L., Chen, Liu, Chen, & Liu (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00484.x · Cited by 35 · see citing works

Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

Powrie, Y. S. L., & Smith, C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1324-0 · Cited by 35 · see citing works

NEW THERAPIES FOR SYSTEMIC LUPUS ERYTHEMATOSUS

Strand, V. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70145-9 · Cited by 32 · see citing works

Ethnic Differences in DNA Methyltransferases Expression in Patients with Systemic Lupus Erythematosus

Wiley, K. L., Treadwell, E. L., Manigaba, K., Word, B. R., & Lyn‐Cook, B. D. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9803-z · Cited by 32 · see citing works

Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus

Chang, D., Chu, S. J., Chen, H. C., Kuo, S. Y., & Lai, J. H. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016576 · Cited by 32 · see citing works

Regulation of Murine Interleukin-10 Production by Dehydroepiandrosterone

Cheng, G.-F., & Tseng, J. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050023889 · Cited by 30 · see citing works

Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

o, L. C., pez-Longo, F. J. L., González, C. M., & Monteagudo, I. (2002) · Pediatric Drugs · doi:10.2165/00128072-200204040-00004 · Cited by 28 · see citing works

Dehydroepiandrosterone Response to the Adrenocorticotropin Test and the Combined Dexamethasone and Corticotropin-Releasing Hormone Test in Patients with Multiple Sclerosis

Kümpfel, T., Bergh, F. T., Frieß, E., Uhr, M., Yassouridis, A., Trenkwalder, C., & Holsboer, F. (1999) · Neuroendocrinology · doi:10.1159/000054505 · Cited by 26 · see citing works

Recognition and Management of Systemic Lupus Erythematosus

Schroeder, J. O., & Euler, H. H. (1997) · Drugs · doi:10.2165/00003495-199754030-00005 · Cited by 25 · see citing works

Autoimmunity, dehydroepiandrosterone (DHEA), and stress

Schwartz, K. E. (2002) · Journal of Adolescent Health · doi:10.1016/s1054-139x(01)00385-8 · Cited by 25 · see citing works

Dehydroepiandrosterone Sulfate (DHEAS) and Testosterone: Relation to HIV Illness Stage and Progression Over One Year

Ferrando, S. J., Rabkin, J. G., & Poretsky, L. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-199910010-00006 · Cited by 25 · see citing works

Update on emerging drug therapies for systemic lupus erythematosus

Mok, C. C. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210903535878 · Cited by 23 · see citing works

Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials

Yuen, S. Y., & Pope, J. E. (2008) · Rheumatology · doi:10.1093/rheumatology/ken230 · Cited by 23 · see citing works

Role of Androgen and Estrogen Receptors for the Action of Dehydroepiandrosterone (DHEA)

Engdahl, C., Lagerquist, M. K., Stubelius, A., Andersson, A., Studer, E., Ohlsson, C., Westberg, L., Carlsten, H., & Forsblad‐d’Elia, H. (2014) · Endocrinology · doi:10.1210/en.2013-1561 · Cited by 23 · see citing works

Exogenous Dehydroepiandrosterone Modified the Expression of T Helper-Related Cytokines in NZB/NZW F1 Mice

Yang, B.-C., Liu, C., Chen, Y. C., & Yu, C. (1998) · Immunological Investigations · doi:10.3109/08820139809070902 · Cited by 23 · see citing works

How accelerated atherosclerosis in SLE has changed our management of the disorder

Hallegua, D. S., & Wallace, D. J. (2000) · Lupus · doi:10.1191/096120300678828181 · Cited by 23 · see citing works

7 Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus

Ginzler, E. M., & Aranow, C. B. (1998) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(98)80032-0 · Cited by 21 · see citing works

Dehydroepiandrosterone Therapy Ameliorates Experimental Autoimmune Myasthenia Gravis in Lewis Rats

Duan, R., Link, H., & Xiao, B. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1022572727408 · Cited by 21 · see citing works

Effects of Oral Prasterone (Dehydroepiandrosterone) on Single‐Dose Pharmacokinetics of Oral Prednisone and Cortisol Suppression in Normal Women

Tetang, G. M. L. M., Blum, R. A., Schwartz, K. E., & Jusko, W. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012742 · Cited by 21 · see citing works

Effects of Prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study

Marder, W., Somers, E. C., Kaplan, M. J., Anderson, M. D., Lewis, E., & McCune, W. J. (2010) · Lupus · doi:10.1177/0961203310371156 · Cited by 21 · see citing works

Primary Cultures of Human Synovial Macrophages Metabolize Androgensa

Cutolo, M., Villaggio, B., BARONE, A., Sulli, A., Accardo, S., Granata, O. M., & CASTAGNETTA, L. A. M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16277.x · Cited by 21 · see citing works

Herbal and Related Remedies

Bartels, C. L., & Miller, S. J. (1998) · Nutrition in Clinical Practice · doi:10.1177/088453369801300102 · Cited by 21 · see citing works

Long-Term Administration of Intravaginal Dehydroepiandrosterone on Regression of Low-Grade Cervical Dysplasia – A Pilot Study

Suh‐Burgmann, E., Sivret, J., Duska, L., del Carmen, M., & Seiden, M. V. (2003) · Gynecologic and Obstetric Investigation · doi:10.1159/000068953 · Cited by 21 · see citing works

Systemic lupus erythematosus: modern strategies for management – a moving target

King, J. K., & Hahn, B. H. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.09.002 · Cited by 18 · see citing works

Treatment of systemic lupus erythematosus in 2006

Sibilia, J. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.09.003 · Cited by 20 · see citing works

An open study of dehydroepiandrosterone in systemic lupus erythematosus

van Vollenhoven, R., Engleman, E. G., & McGuire, J. L. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370906 · Cited by 157 · see citing works

Dehydroepiandrosterone treatment of women with mild‐to‐moderate systemic lupus erythematosus: A multicenter randomized, double‐blind, placebo‐controlled trial

Chang, D., Lan, J., Lin, H., & Luo, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10615 · Cited by 164 · see citing works

Dehydroepiandrosterone for systemic lupus erythematosus

Crosbie, D., Black, C., McIntyre, L., Royle, P., & Thomas, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005114.pub2 · Cited by 54 · see citing works

Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.

van Vollenhoven, R., & McGuire, J. L. (1996) · PubMed · Cited by 16 · see citing works

Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.

van Vollenhoven, R., Morabito, L. M., Engleman, E. G., & McGuire, J. L. (1998) · PubMed · Cited by 118 · see citing works